Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hos...

por Puzniak, Laura, Dillon, Ryan, Lodise, Thomas
Publicado 2023

2414. Real-World Evaluation of Patient Characteristics and Outcomes of Patients Treated With Ceftolozane/Tazobactam Across 253 US Hospitals

por Puzniak, Laura, Fu, Rao, Gundrum, Jake, Lodise, Thomas P
Publicado 2018

Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP)

por Shorr, Andrew F., Puzniak, Laura A., Biswas, Pinaki, Niederman, Michael S.
Publicado 2015

2200. Cost-effectiveness of Ceftolozane/Tazobactam for Treating Ventilated Nosocomial Bacterial Pneumonia

por Naik, Jaesh, Yang, Joe, Elsea, David, Critchlow, Simone, Puzniak, Laura
Publicado 2019

Retrospective Real-World Evaluation of Outcomes in Patients with Skin and Soft Structure Infections Treated with Tedizolid in an Outpatient Setting

por Kullar, Ravina, Puzniak, Laura A., Swindle, Jason P., Lodise, Thomas
Publicado 2020

Real-world use of ceftolozane/tazobactam: a systematic literature review

por Puzniak, Laura, Dillon, Ryan, Palmer, Thomas, Collings, Hannah, Enstone, Ashley
Publicado 2021

Systematic Literature Review of Real-world Evidence of Ceftolozane/Tazobactam for the Treatment of Respiratory Infections

por Puzniak, Laura, Dillon, Ryan, Palmer, Thomas, Collings, Hannah, Enstone, Ashley
Publicado 2021

398. Multicenter Evaluation of Outcomes of SARS-CoV-2 Positive Patients Treated at Rural vs Urban Hospitals in the United States

por Bauer, Karri A, Yu, Kalvin, Gupta, Vikas, Puzniak, Laura A
Publicado 2021

156. Evaluation of Trends in Antimicrobial Use and Proportion of Culture Positive Gram-Negative/Gram-Positive Pathogens Comparing Prior to and During the SARS-CoV-2 Pandemic: A Mul...

por Puzniak, Laura A, Bauer, Karri A, Yu, Kalvin, Gupta, Vikas
Publicado 2021

Real-world Analysis of Prescribing Patterns and Susceptibility of Ceftolozane/Tazobactam (C/T) Treatment using an Electronic Medical Record (EMR) Database in the United States

por Pogue, Jason M, Puzniak, Laura, Merchant, Sanjay, Sanagaram, Rahul, Rhee, Elizabeth
Publicado 2017

Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

por Raman, Gowri, Avendano, Esther E., Chan, Jeffrey, Merchant, Sanjay, Puzniak, Laura
Publicado 2018

Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial

por Lodise, Thomas, Yang, Joe, Puzniak, Laura A., Dillon, Ryan, Kollef, Marin
Publicado 2020

A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections

por Hart, Delaney E, Gallagher, Jason C, Puzniak, Laura A, Hirsch, Elizabeth B
Publicado 2021

1314. Descriptive Epidemiology of 30-day Readmissions among Survivors of Hospitalization with Bacterial Nosocomial Pneumonia in the US, 2012-2019

por Zilberberg, Marya, Nathanson, Brian, Puzniak, Laura A, Zilberberg, Noah, Shorr, Andrew F
Publicado 2021

221. Evaluation of Rates of Culture Positive Blood Stream Pathogens Prior to and During the SARS-CoV-2 Pandemic: A Multicenter Evaluation

por Puzniak, Laura A, Bauer, Karri A, Yu, Kalvin, Moise, Pamela, Gupta, Vikas
Publicado 2021

Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012–201...

por Zilberberg, Marya D., Nathanson, Brian H., Puzniak, Laura A., Shorr, Andrew F.
Publicado 2021

Impact of the use of local fidaxomicin treatment algorithms for managing Clostridium difficile infection in hospitalized patients in southeastern United States

por Cho, Jonathan C., Estrada, Sandy J., Kisgen, Jamie J., Davis, Angelina, Puzniak, Laura
Publicado 2018

2270. Initial Treatment Selection Among Patients with Recurrent Pseudomonas aeruginosa (PSA) Infections (Infxs): Does Prior PSA Antibiotic Susceptibility Results Effect Subsequent...

por Puzniak, Laura, Gupta, Vikas, Dillon, Ryan J, Yu, Kalvin, Murray, John, Lodise, Thomas
Publicado 2019

1628. Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia

por Caffrey, Aisling, Bodo, Emily C, Lopes, Vrishali, Puzniak, Laura A, LaPlante, Kerry
Publicado 2020

1596. Ceftolozane/tazobactam (Zerbaxa) for the Treatment of Pseudomonas aeruginosa (PSA) Bacteremia: A Systematic Literature Review (SLR)

por Dillon, Ryan J, Khankhel, Zarmina S, De Anda, Carisa, Bruno, Christopher, Puzniak, Laura A
Publicado 2020